Nautilus Biotechnolgy (NAUT) Analyst & Key Data

Analyst Consensus

Buy0 analysts

Buy

Updated Sep 12, 2026

Total Analysts0

Buy

3

Hold

1

Sell

1

Ratings

Updated Sep 12, 2026

Overall Rating

C

DCF Score1.0 / 5

Debt / Equity Score3.0 / 5

Price / Book Score3.0 / 5

Price / Earnings Score1.0 / 5

ROA Score1.0 / 5

ROE Score1.0 / 5

Valuation

Current Stock Price

$1.02

Median Target-100.00%

$0.00

Potential downside vs current price

DCF Value-114.37%

-$0.15

Potential downside vs current price

Current Stock Price

$1.02

Median Target-100.00%

$0.00

Potential downside vs current price

DCF Value-114.37%

-$0.15

Potential downside vs current price

Analyst Consensus

Buy0 analysts

Buy

Updated Sep 12, 2026

Total Analysts0

Buy

3

Hold

1

Sell

1

Ratings

Updated Sep 12, 2026

Overall Rating

C

DCF Score1.0 / 5

Debt / Equity Score3.0 / 5

Price / Book Score3.0 / 5

Price / Earnings Score1.0 / 5

ROA Score1.0 / 5

ROE Score1.0 / 5

Valuation

Current Stock Price

$1.02

Median Target-100.00%

$0.00

Potential downside vs current price

DCF Value-114.37%

-$0.15

Potential downside vs current price

Current Stock Price

$1.02

Median Target-100.00%

$0.00

Potential downside vs current price

DCF Value-114.37%

-$0.15

Potential downside vs current price

Nautilus Biotechnolgy, Inc.